TFF Pharmaceuticals, Inc. (TFFP)
NASDAQ: TFFP · Real-Time Price · USD
0.370
-0.002 (-0.62%)
Nov 21, 2024, 12:34 PM EST - Market open

TFF Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
-18.52-21.24-31.77-31.04-18.57-11.87
Upgrade
Depreciation & Amortization
0.550.50.390.11--
Upgrade
Asset Writedown & Restructuring Costs
-0.75----
Upgrade
Stock-Based Compensation
2.392.934.253.552.190.59
Upgrade
Other Operating Activities
0-0.5----
Upgrade
Change in Accounts Payable
0.580.04-0.580.210.860.01
Upgrade
Change in Unearned Revenue
0.17-0.030.080.030.02-
Upgrade
Change in Other Net Operating Assets
2.231.510.29-2.41-1.120.05
Upgrade
Operating Cash Flow
-12.59-16.04-27.34-29.56-16.62-11.22
Upgrade
Capital Expenditures
-0.05-0.09-1.55-0.87-1.1-
Upgrade
Investing Cash Flow
-0.05-0.09-1.55-0.87-1.1-
Upgrade
Issuance of Common Stock
5.665.1211.7528.8824.9921.85
Upgrade
Other Financing Activities
-0.14-0.11----
Upgrade
Financing Cash Flow
5.535.0111.7528.8824.9929.05
Upgrade
Foreign Exchange Rate Adjustments
-0.01-0.01-0.040.03-0.07-
Upgrade
Net Cash Flow
-7.12-11.13-17.18-1.517.2117.83
Upgrade
Free Cash Flow
-12.64-16.13-28.89-30.43-17.72-11.22
Upgrade
Free Cash Flow Margin
-1088.29%-2198.34%-5827.59%-34511.26%--
Upgrade
Free Cash Flow Per Share
-3.95-9.00-24.09-30.64-21.69-40.61
Upgrade
Levered Free Cash Flow
-5.16-8.75-15.06-19.22-10.85-8.73
Upgrade
Unlevered Free Cash Flow
-5.16-8.75-15.06-19.22-10.85-8.73
Upgrade
Change in Net Working Capital
-3.09-1.6-1.722.150.251.83
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.